The Discounted Cash Flow (DCF) valuation of ImmunoGen Inc (IMGN) is (30.51) USD. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on DCF is -197.7%.
Based on the latest price of 31.23 USD and our DCF valuation, ImmunoGen Inc (IMGN) is a sell. selling IMGN stocks now will result in a potential gain of 197.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 10.5% | 8.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (79.36) - (18.72) | (30.51) |
| Upside | -354.1% - -159.9% | -197.7% |